世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040710

抗血栓薬の世界市場(2024-2028)

TechNavio

Global Antithrombotic Drugs Market 2024-2028

発刊日 2024/07/03

言語英語

体裁PDF/161ページ

ライセンス/価格161ページ

0000040710

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

抗血栓薬市場は、2023年から2028年にかけて217億8,380万米ドル成長すると予測されており、予測期間中にCAGRは7.68%で加速します。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。凝固障害の有病率の増加、新規経口抗凝固薬のイントロダクション、強力なR&Dパイプラインの構築などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 投与経路別
      ◇ 経口
      ◇ 注射可能
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、抗凝固解毒剤の出現が、今後数年間の抗血栓薬市場の成長を促進する主な理由の1つであることを特定しています。また、市場に焦点を当てた企業の戦略的パートナーシップや買収、および市場に焦点を当てた新たな開発の成長は、市場でのかなりの需要につながるでしょう。

抗血栓薬市場に関するレポートは、次の分野をカバーしています。

  • 抗血栓薬市場の規模
  • 抗血栓薬市場の予測
  • 抗血栓薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Aspen Pharmacare Holdings Ltd.
    ➣ AstraZeneca PLC
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Fresenius Kabi AG
    ➣ GlaxoSmithKline PLC
    ➣ Hikma Pharmaceuticals PL
    ➣ Johnson and Johnson Services Inc.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ 大塚製薬(Otsuka Pharmaceutical Co. Ltd.)
    ➣ Pfizer Inc., Sanofi SA
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

目次

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Antithrombotic Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Antithrombotic Drugs Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Injectable - Market size and forecast 2023-2028
Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Chart on Injectable - Year-over-year growth 2023-2028 (%)
Data Table on Injectable - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2023-2028
Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacy - Market size and forecast 2023-2028
Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. - Overview
Aspen Pharmacare Holdings Ltd. - Business segments
Aspen Pharmacare Holdings Ltd. - Key offerings
Aspen Pharmacare Holdings Ltd. - Segment focus
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.11 Fresenius Kabi AG
Fresenius Kabi AG - Overview
Fresenius Kabi AG - Business segments
Fresenius Kabi AG - Key offerings
Fresenius Kabi AG - Segment focus
12.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd. - Overview
Otsuka Pharmaceutical Co. Ltd. - Product / Service
Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Antithrombotic Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits33: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Route of Administration
Exhibits35: Data Table on Comparison by Route of Administration
Exhibits36: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Route of Administration ($ million)
Exhibits45: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Distribution Channel ($ million)
Exhibits63: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Aspen Pharmacare Holdings Ltd. - Overview
Exhibits114: Aspen Pharmacare Holdings Ltd. - Business segments
Exhibits115: Aspen Pharmacare Holdings Ltd. - Key offerings
Exhibits116: Aspen Pharmacare Holdings Ltd. - Segment focus
Exhibits117: AstraZeneca Plc - Overview
Exhibits118: AstraZeneca Plc - Product / Service
Exhibits119: AstraZeneca Plc - Key news
Exhibits120: AstraZeneca Plc - Key offerings
Exhibits121: Bayer AG - Overview
Exhibits122: Bayer AG - Business segments
Exhibits123: Bayer AG - Key news
Exhibits124: Bayer AG - Key offerings
Exhibits125: Bayer AG - Segment focus
Exhibits126: Boehringer Ingelheim International GmbH - Overview
Exhibits127: Boehringer Ingelheim International GmbH - Product / Service
Exhibits128: Boehringer Ingelheim International GmbH - Key news
Exhibits129: Boehringer Ingelheim International GmbH - Key offerings
Exhibits130: Bristol Myers Squibb Co. - Overview
Exhibits131: Bristol Myers Squibb Co. - Product / Service
Exhibits132: Bristol Myers Squibb Co. - Key news
Exhibits133: Bristol Myers Squibb Co. - Key offerings
Exhibits134: Daiichi Sankyo Co. Ltd. - Overview
Exhibits135: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits136: Daiichi Sankyo Co. Ltd. - Key news
Exhibits137: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits138: Eli Lilly and Co. - Overview
Exhibits139: Eli Lilly and Co. - Product / Service
Exhibits140: Eli Lilly and Co. - Key news
Exhibits141: Eli Lilly and Co. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Overview
Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits144: F. Hoffmann La Roche Ltd. - Key news
Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits147: Fresenius Kabi AG - Overview
Exhibits148: Fresenius Kabi AG - Business segments
Exhibits149: Fresenius Kabi AG - Key offerings
Exhibits150: Fresenius Kabi AG - Segment focus
Exhibits151: Hikma Pharmaceuticals Plc - Overview
Exhibits152: Hikma Pharmaceuticals Plc - Business segments
Exhibits153: Hikma Pharmaceuticals Plc - Key news
Exhibits154: Hikma Pharmaceuticals Plc - Key offerings
Exhibits155: Hikma Pharmaceuticals Plc - Segment focus
Exhibits156: Novartis AG - Overview
Exhibits157: Novartis AG - Business segments
Exhibits158: Novartis AG - Key news
Exhibits159: Novartis AG - Key offerings
Exhibits160: Novartis AG - Segment focus
Exhibits161: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibits162: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibits163: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibits164: Sanofi SA - Overview
Exhibits165: Sanofi SA - Business segments
Exhibits166: Sanofi SA - Key news
Exhibits167: Sanofi SA - Key offerings
Exhibits168: Sanofi SA - Segment focus
Exhibits169: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits170: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits172: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits174: Viatris Inc. - Overview
Exhibits175: Viatris Inc. - Business segments
Exhibits176: Viatris Inc. - Key news
Exhibits177: Viatris Inc. - Key offerings
Exhibits178: Viatris Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Information sources
Exhibits184: Data validation
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Data synthesis
Exhibits187: 360 degree market analysis
Exhibits188: List of abbreviations

この商品のレポートナンバー

0000040710

TOP